[在手术治疗同时发生的双侧多种癌症后出现的多形侵袭性叶叶状癌]
Kenichi Sakurai1, Shuhei Suzuki, Keita Adachi
1Dept. of Breast and Endocrine Surgery, Nippon Dental University Hospital.
Gan to kagaku ryoho. Cancer & chemotherapy
|January 17, 2026
概括
本案例研究突出了一个罕见的形侵袭性叶状腺癌的例子,在治疗多种乳腺癌后发展. 需要进一步的研究来澄清这种侵略性亚型的预后和治疗.
科学领域:
- 在瘤学瘤学.
- 病理学 病理学 病理学
背景情况:
- 一名54岁的妇女呈现出右乳腺损伤.
- 最初的活检显示了侵入性导管癌.
研究的目的:
- 报告多种ipsilateral乳腺癌治疗后出现的多形侵袭性叶膜癌 (ILC) 的病例.
- 讨论这种罕见的呈现所带来的诊断和治疗挑战.
主要方法:
- 最初的诊断是通过针活检.
- 手术管理包括乳房切除和带淋巴结解剖.
- 切除瘤的组织病理学检查.
- 术后辅助疗法 (化疗,放射,内分泌疗法).
- 后续诊断和手术治疗复发性多形ILC.
主要成果:
- 最初的呈现:侵入性导管癌 (IDC) 和侵入性叶状癌 (ILC).
- 治疗后复发:多形性ILC与多个子结节.
- 瘤特征:最初和复发的瘤均为ER/PgR阴性和HER2阴性,具有不同的Ki-67指数.
- 复发的瘤:多形ILC,22毫米,ER阴性,PGR阳性,HER2阴性,Ki-6725%.
结论:
- 在治疗其他乳腺癌类型后,乐形ILC可能会发展.
- 形ILC的预后和最佳治疗策略尚不清楚,需要谨慎管理.
- 这一案例强调了对有多种乳腺癌病史的患者进行警的随访的重要性.
更多相关视频
13:35Endoscopic Bilateral Nipple-sparing Mastectomy via a Single Axillary Incision with Immediate Pre-pectoral Implant-based Breast Reconstruction
Published on: May 17, 2024
4.1K
08:15A Hepatocellular Cancer Patient-Derived Organoid Xenograft Model to Investigate Impact of Liver Regeneration on Tumor Growth
Published on: February 2, 2024
1.4K
相关概念视频
Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Metastasis
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Cancer Stem Cells and Tumor Maintenance
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
Skin Cancer
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
